Amicus sets $315,000 price for new Fabry disease treatment
MEI Pharma, Inc a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and advance new therapies for cancer.
Biogen’s muscle drug Spinraza too costly for Britain
MEI Pharma, Inc a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and advance new therapies for cancer.